Everything You Need to Know About Compounded GLP-1s in 2026 | Karla Palmer

Compounded GLP-1 medications have become one of the most talked-about topics in healthcare, but there’s also a tremendous amount of confusion surrounding their legality, safety, and role in patient care. In this episode of Everything GLP-1, Dr. Tom Lavin sits down with Karla Palmer, one of the nation’s leading FDA and DEA regulatory attorneys, to break through the misinformation and explain what patients need to know.

With more than three decades of experience advising pharmacies, manufacturers, and healthcare providers, Karla explains how compounded medications have been a vital part of American healthcare for decades, why 503A compounding pharmacies exist, and what changed after the GLP-1 shortages officially ended. Together, they discuss the important differences between legally compounded medications and unregulated research peptides, how patients can identify safe sources of treatment, and why physician oversight remains essential.

Whether you’re currently taking a GLP-1, considering treatment, or simply trying to understand the rapidly changing landscape, this conversation offers clear, practical insight into the future of compounded GLP-1s, peptide therapies, and FDA regulation. It’s an essential episode for anyone who wants to make informed decisions about their health with facts instead of headlines.

https://www.yourera.com/

Hosted on Acast. See acast.com/privacy for more information.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(11)

Why Sourcing and Testing Matter in Compounded Peptides | Trey (Joseph) Pierre

In this episode of Everything GLP-1, Dr. Tom Lavin speaks with Trey (Joseph) Pierre, who heads Galleria Medical Pharmacy in New Orleans and ranks among the top compounding pharmacists in the Gulf Sout...

5 Elo 22min

Inside the Regulatory Battle Shaping Compounded GLP-1 Access | Scott Brunner

In this episode of Everything GLP-1, Dr. Tom Lavin speaks with Scott Brunner, CEO and President of the Alliance for Pharmacy Compounding, to examine how pharmacy compounding has shaped patient access ...

22 Heinä 33min

Preventing Metabolic Syndrome with GLP-1s | Samantha Spansel

"Everything GLP-1" is a podcast to discuss just that. GLP-1s are everywhere, but there's no one, great place to get quality, professional opinions that can help inform your health journey. Join Dr. To...

10 Kesä 32min

How Weight Loss Treatments Evolved | Ramsey Hare

This episode features Ramsey Hare, Regulatory Compliance Specialist with Lavin National, a former bariatric patient and current GLP-1 patient, for a discussion with Dr. Tom about the evolution of weig...

28 Touko 33min

GLP-1s Are Changing Patient Care | Gibb Clark (part 2)

""Everything GLP-1" is a podcast to discuss just that. GLP-1s are everywhere, but there's no one, great place to get quality, professional opinions that can help inform your health journey. Join Dr. T...

12 Touko 43min